Centre buying Covishield at 215, Covaxin at 225
"We are on path to achieving the target of 50 crore doses by July 31, this is crucial towards meeting our target coverage by end of this year," the senior official said.

"We are on path to achieving the target of 50 crore doses by July 31, this is crucial towards meeting our target coverage by end of this year," the senior official said.
The new study, published on Tuesday in the journal Cell Reports Medicine, examined whether a single dose would achieve greater public health benefit than two doses by allowing protection of a larger population more quickly.
"Enrollment in the trial has been proceeding as planned and the companies expect to reach its initial target of up to 30,000 participants next week", they said in a joint statement on Saturday.
“Availability of ancillary components, rapid capacity ramp-up, strengthening supply networks and fair-share between domestic and global requirement will be key for India to emerge as the global supply hub for the Covid-19 vaccine”